Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Grossmann

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neuroradiology|September 5, 2015
Somatic mutations associated with MRI-derived volumetric features in glioblastomaDavid A Gutman, William D Dunn, Patrick Grossmann, et al.
Plos Medicine|December 1, 2018
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics studyAhmed Hosny, Chintan Parmar, Thibaud P Coroller, et al.
Scientific Reports|August 8, 2015
Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancerChintan Parmar, Ralph T H Leijenaar, Patrick Grossmann, et al.
Neuro-Oncology|May 13, 2017
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumabPatrick Grossmann, Vivek Narayan, Ken Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2015
CT-based radiomic signature predicts distant metastasis in lung adenocarcinomaThibaud P Coroller, Patrick Grossmann, Ying Hou, et al.
Elife|July 22, 2017
Defining the biological basis of radiomic phenotypes in lung cancerPatrick Grossmann, Olya Stringfield, Nehme El-Hachem, et al.
Annals of the Rheumatic Diseases|October 27, 2009
Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor functionVelia Gerl, Alexandra Lischka, Daniel Panne, et al.
Scientific Reports|June 25, 2016
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Scientific Reports|July 1, 2017
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Scientific Reports|May 11, 2016
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neuroradiology|September 5, 2015
Somatic mutations associated with MRI-derived volumetric features in glioblastomaDavid A Gutman, William D Dunn, Patrick Grossmann, et al.
Plos Medicine|December 1, 2018
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics studyAhmed Hosny, Chintan Parmar, Thibaud P Coroller, et al.
Scientific Reports|August 8, 2015
Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancerChintan Parmar, Ralph T H Leijenaar, Patrick Grossmann, et al.
Neuro-Oncology|May 13, 2017
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumabPatrick Grossmann, Vivek Narayan, Ken Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2015
CT-based radiomic signature predicts distant metastasis in lung adenocarcinomaThibaud P Coroller, Patrick Grossmann, Ying Hou, et al.
Elife|July 22, 2017
Defining the biological basis of radiomic phenotypes in lung cancerPatrick Grossmann, Olya Stringfield, Nehme El-Hachem, et al.
Annals of the Rheumatic Diseases|October 27, 2009
Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor functionVelia Gerl, Alexandra Lischka, Daniel Panne, et al.
Scientific Reports|June 25, 2016
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Scientific Reports|July 1, 2017
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Scientific Reports|May 11, 2016
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Pageof 3